BigOmics Raises $1.85M to Revolutionize Omics Data Analytics

Bellinzona, Switzerland, December 10, 2021 – BigOmics Analytics SA (“BigOmics”), a Swiss biodata analytics startup, announced today that it raised a total of $1.85 million in financing. This funding will allow the company to expand its team and to commercialize its governed self-service analytics (GSSA) platforms to empower life scientists.

BigOmics raised $1.42 million on the first closing of its pre-series A round in October, 2021, after graduating from the US-based Alchemist Accelerator. The round, coordinated by TiVentures along with the participation of Century Oak Capital, Champion Hill Ventures and Acequia Capital, comes on top of the $430,000 funding raised earlier this year in a seed round from TiVentures and ADM Partners. Business angels Raul Vejar and Mark Jalabert, as well as Nathan Kaiser from the Swiss ICT Investor Club (SICTIC) network also joined the pre-series A round which remains open until January 2022 for additional funding. 

BigOmics’ vision is to disrupt omics data analysis processes and accelerate scientific discovery. The company supports BioTech & Pharma companies, as well as academic labs, in the field of data-driven therapeutics and precision medicine to significantly reduce data analysis time and costs. BigOmics’ platforms enable omics data analysis stakeholders to communicate in an interactive manner instead of exchanging static analysis reports. They allow bioinformaticians to delegate part of their routine workload to biologists, while empowering the latter to take more control of their data analysis through a user-friendly interface. It is a win-win proposition for both biologists and bioinformaticians at enterprises and balances data quality and analysis agility.

Omics Playground is BigOmics’ flagship platform for visualizing and analyzing transcriptomics and proteomics data types. To date, the platform has been accessed by more than 16,000 users and the company has closed enterprise subscriptions with three BioTech & Pharma companies and two academic labs. 

Dr. Murodzhon Akhmedov (CEO and Co-Founder) said: “We are excited to have been supported by dynamic VCs and angels in this new financing round in our mission to solve the omics data analysis bottleneck. This funding will enable us to expand our team and to actively commercialize our platform solutions.” 

Dr. Ivo Kwee (CTO and Co-Founder) added: “The closing of this first part of pre-series A funding will allow us to further support the development of our platforms and improve product-market-fit. We want to build the smoothest and most user-friendly platforms for omics data with a world-class team.”

Dr. Lorenzo Leoni (Managing Partner of TiVentures) commented: “With its unique software platforms, BigOmics can make a contribution to making drug development more efficient. Placed at the intersection of Biomedicine and Data Analytics, BigOmics represents the ideal company for TiVentures, focused on building high-value companies from advanced technologies.”

About BigOmics Analytics

BigOmics is a spin-off of IOR / USI and IDSIA / SUPSI. It is a Swiss data analytics startup with the vision of democratizing biodata analysis in digital healthcare to accelerate scientific discoveries in medicine.

For more information, visit

About the Alchemist Accelerator

Alchemist is a global venture-backed accelerator focused on promoting the development of seed-stage ventures that monetize from enterprises, with a strong emphasis on companies with distinguished technical founders.

For more information, visit

About TiVentures

TiVentures is a seed investment fund owned by the Fondazione Centenario Banca Stato (Switzerland) that invests in early stage companies with innovative technologies and high growth potential, principally in southern Switzerland. 

For more information, visit

About Century Oak Capital

Century Oak Capital  focuses on investing in a wide range of technology companies (food delivery, fintech, healthcare, etc..) with scalable business models. 

For more information, visit

About Champion Hill Ventures

Champion Hill Ventures invests at the earliest stages in non-consensus ideas, markets, founders and technologies across the United States and occasionally elsewhere.

For more information, visit

About Acequia Capital

Acequia Capital provides both venture capital and advice to early stage founders, with a focus on innovative technology companies.

For more information, visit

About ADM Partners

ADM Partners provide strategic, business and advisory services to companies operating in various sectors, as well as equity capital.

For more information, visit


Swiss ICT Investor Club (SICTIC) connects smart money investors to Swiss seed and early-stage technology startups.

For more information, visit